Trends in Access to Medications for Opioid Use Disorder.

ABSTRACT:

Importance

Medicaid, the largest payer for medications for opioid use disorder (MOUD), disenrolled more than 19.1 million individuals by March 2024 after the continuous coverage requirement ended in April 2023-a process termed Medicaid unwinding-but the impact on buprenorphine receipt remains unknown.

Objective

To assess the association between Medicaid unwinding and dispensing of prescription buprenorphine, overall and by payment sources nationally and by state.

Design, setting, and participants

Cross-sectional study of buprenorphine dispensing (age ≥18 years) from April 2020 to March 2024 using the IQVIA Longitudinal Prescription (LRx) database containing more than 90% of US retail pharmacy claims. Interrupted time-series estimated levels and trends of buprenorphine

SUBMITTER: Gupta S 

PROVIDER: S-EPMC11971676 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature